|
|
News Breaks | | | | January 2, 2013 | | 06:43 EDT |  | BCR | C.R. Bard upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded C.R. Bard based on expectations for a resolution of the Gore patent litigation, a positive outcome in the LEVANT 2 trial, and higher earnings revisions. Price target raised to $116 from $110. | |
|
News For BCR From The Last 14 Days Check below for free stories on BCR the last two weeks. |
|
|
| May 13, 2013 | | 17:08 EDT |  | BCR | C.R. Bard to pay $48.26M to U.S to resolve false claims act accusations
 Subscribe for More Information | |
|
|
|
|
|
|
